1-4 of 4
Marcos Gonzalez, PhD
Close
Sort by
Journal Articles

Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Updated Results of the Spanish PETHEMA LPA99 Trial Using ATRA and Anthracycline Monochemotherapy.

Miguel A. Sanz, PhD, Pau Montesinos, MD, Edo Vellenga, PhD, Chelo Rayon, PhD, Ricardo Parody, PhD, Javier de la Serna, PhD, Juan Bergua, PhD, Angel Leon, PhD, Silvia Negri, PhD, Concha Rivas, PhD, Salut Brunet, PhD, Marcos Gonzalez, PhD, Jordi Esteve, PhD, Bob Lowenberg, PhD
Journal: Blood
Blood (2007) 110 (11): 590.
https://doi.org/10.1182/blood.V110.11.590.590
Published: 2007
Journal Articles

Incidence and Risk Factors for Thrombosis in Patients with Acute Promyelocytic Leukemia. Experience of the PETHEMA LPA96 and LPA99 Protocols.

Pau Montesinos, MD, Javier de la Serna, PhD, Edo Vellenga, PhD, Consuelo Rayon, PhD, Juan Bergua, PhD, Ricardo Parody, PhD, Jordi Esteve, PhD, Marcos Gonzalez, PhD, Salud Brunet, PhD, Miguel Sanz, PhD
Journal: Blood
Blood (2006) 108 (11): 1503.
https://doi.org/10.1182/blood.V108.11.1503.1503
Published: 2006
Journal Articles

FLT3 Mutations in a Large Series of Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Anthracycline Monochemotherapy.

Pau Montesinos, MD, Marcos Gonzalez, PhD, Maria Calasanz, PhD, Pascual Bolufer, PhD, Dolors Colomer, PhD, Jose Roman, PhD, Maria Teresa Gomez, PhD, Joaquin Martinez, PhD, Elena Amutio, PhD, Miguel Sanz, PhD
Journal: Blood
Blood (2006) 108 (11): 2348.
https://doi.org/10.1182/blood.V108.11.2348.2348
Published: 2006
Journal Articles

Retinoic Acid Syndrome in Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Anthracycline Monochemotherapy.

Pau Montesinos, MD, Juan Bergua, PhD, Guillermo Martin, PhD, Javier de la Serna, PhD, Edo Vellenga, PhD, Consuelo Rayon, PhD, Ricardo Parody, PhD, Jordi Esteve, PhD, Marcos Gonzalez, PhD, Jose Gonzalez, PhD, Miguel Sanz, PhD
Journal: Blood
Blood (2006) 108 (11): 2010.
https://doi.org/10.1182/blood.V108.11.2010.2010
Published: 2006